Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J.L. Heerspink(University Medical Center Groningen), Chris Vercammen, Xavier Warling, George L. Bakris(Pennsylvania State System of Higher Education), Carol A. Pollock(The University of Sydney), Doris Chan, Shamasunder Acharya, Zoltán Endre(Prince of Wales Hospital), Fan Fan Hou(Southern Medical University), John J.V. McMurray(University of Glasgow), Vlado Perkovic(New South Wales Department of Health), Ana María Cusumano, Melissa Wigderson(AbbVie (United States)), Rudolf Prager, Michel Jadoul(Cliniques Universitaires Saint-Luc), Richard J. MacIsaac, Sheldon W. Tobe(Sunnybrook Health Science Centre), Timothy M. E. Davis(Liberty University), Dick de Zeeuw(University Medical Center Groningen), Pablo E. Pérgola(Renal Associates P. A.), Donald Kohan(University of Utah), Alice Schmidt, Margaret B. Fraenkel, Dalane W. Kitzman(Wake Forest University), Tingting Yi(AbbVie (United States)), Joel Z. Melnick(AbbVie (United States)), Alicia Elbert, Nigel D. Toussaint(The Royal Melbourne Hospital), A Zucchini, Luis I. Juncos, Michael G. Miller(AbbVie (United States)), Javier de Arteaga, Michael Suranyi(Liverpool Hospital), Andres Alvarisqueta(AbbVie (United States)), Ricardo Correa-Rotter(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Duncan Cooke, Martin Gallagher(The George Institute for Global Health), Gustavo Greloni, Hirofumi Makino(Okayama University Hospital), Juan Carlos Santos, Gert Mayer(Statistics Austria), Simon D. Roger(Gosford Hospital), Jean Hougardy, Daniel Vogel, Dennis L. Andress(Abbott (United Kingdom)), Hans‐Henrik Parving(University of Copenhagen), Stephen Stranks, Eduardo Farias, Augusto Vallejos, Laura Maffei
Cited by 609
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k